GeoVax Labs (GOVX) Competitors $2.61 -0.30 (-10.31%) (As of 11/20/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends GOVX vs. ANIX, KPTI, ELYM, CHRS, IMUX, MNOV, MIST, ORMP, ADAG, and IVVDShould you be buying GeoVax Labs stock or one of its competitors? The main competitors of GeoVax Labs include Anixa Biosciences (ANIX), Karyopharm Therapeutics (KPTI), Eliem Therapeutics (ELYM), Coherus BioSciences (CHRS), Immunic (IMUX), MediciNova (MNOV), Milestone Pharmaceuticals (MIST), Oramed Pharmaceuticals (ORMP), Adagene (ADAG), and Invivyd (IVVD). These companies are all part of the "pharmaceutical products" industry. GeoVax Labs vs. Anixa Biosciences Karyopharm Therapeutics Eliem Therapeutics Coherus BioSciences Immunic MediciNova Milestone Pharmaceuticals Oramed Pharmaceuticals Adagene Invivyd Anixa Biosciences (NASDAQ:ANIX) and GeoVax Labs (NASDAQ:GOVX) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, risk, community ranking, institutional ownership, dividends, earnings, analyst recommendations, media sentiment and profitability. Do analysts rate ANIX or GOVX? Anixa Biosciences presently has a consensus target price of $7.00, suggesting a potential upside of 129.89%. GeoVax Labs has a consensus target price of $13.25, suggesting a potential upside of 407.66%. Given GeoVax Labs' higher probable upside, analysts clearly believe GeoVax Labs is more favorable than Anixa Biosciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Anixa Biosciences 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 3.50GeoVax Labs 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 2 Strong Buy rating(s) 3.33 Which has better earnings and valuation, ANIX or GOVX? Anixa Biosciences has higher revenue and earnings than GeoVax Labs. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAnixa Biosciences$210K466.60-$9.81M-$0.39-7.81GeoVax Labs$80K307.98-$25.97MN/AN/A Is ANIX or GOVX more profitable? Anixa Biosciences' return on equity of -54.79% beat GeoVax Labs' return on equity.Company Net Margins Return on Equity Return on Assets Anixa BiosciencesN/A -54.79% -50.37% GeoVax Labs N/A -809.87%-349.34% Do insiders & institutionals have more ownership in ANIX or GOVX? 29.1% of Anixa Biosciences shares are owned by institutional investors. Comparatively, 6.1% of GeoVax Labs shares are owned by institutional investors. 22.6% of Anixa Biosciences shares are owned by insiders. Comparatively, 5.7% of GeoVax Labs shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Does the media prefer ANIX or GOVX? In the previous week, GeoVax Labs had 4 more articles in the media than Anixa Biosciences. MarketBeat recorded 11 mentions for GeoVax Labs and 7 mentions for Anixa Biosciences. GeoVax Labs' average media sentiment score of 0.85 beat Anixa Biosciences' score of 0.24 indicating that GeoVax Labs is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Anixa Biosciences 0 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Neutral GeoVax Labs 1 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Does the MarketBeat Community favor ANIX or GOVX? Anixa Biosciences received 3 more outperform votes than GeoVax Labs when rated by MarketBeat users. However, 95.24% of users gave GeoVax Labs an outperform vote while only 69.70% of users gave Anixa Biosciences an outperform vote. CompanyUnderperformOutperformAnixa BiosciencesOutperform Votes2369.70% Underperform Votes1030.30% GeoVax LabsOutperform Votes2095.24% Underperform Votes14.76% Which has more volatility and risk, ANIX or GOVX? Anixa Biosciences has a beta of 0.84, suggesting that its stock price is 16% less volatile than the S&P 500. Comparatively, GeoVax Labs has a beta of 3.1, suggesting that its stock price is 210% more volatile than the S&P 500. SummaryAnixa Biosciences beats GeoVax Labs on 9 of the 16 factors compared between the two stocks. Ad DarwinNew Year, New Opportunity! 2 AI Stocks Under $10 Ready to SoarAs we step into 2025, artificial intelligence (AI) stocks continue to dominate headlines, and now is the perfect moment to position yourself for the coming year’s potential. Our latest research has uncovered two must-buy AI stocks currently trading under $10/share – an affordable entry with promising growth potential. These stocks are flying under the radar, but it’s only a matter of time before they gain mainstream attention.👉 Click here to access your FREE report now! Get GeoVax Labs News Delivered to You Automatically Sign up to receive the latest news and ratings for GOVX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart GOVX vs. The Competition Export to ExcelMetricGeoVax LabsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$24.64M$6.45B$5.04B$8.81BDividend YieldN/A8.11%5.16%4.07%P/E RatioN/A10.78130.5317.82Price / Sales307.98243.701,183.8674.55Price / CashN/A22.1633.6132.53Price / Book0.815.474.684.68Net Income-$25.97M$153.61M$119.23M$226.08M7 Day PerformanceN/A-2.00%-1.83%-1.04%1 Month Performance16.52%-7.46%-3.61%1.04%1 Year Performance-66.54%31.82%31.74%26.28% GeoVax Labs Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)GOVXGeoVax Labs3.1629 of 5 stars$2.61-10.3%$13.25+407.7%-67.4%$24.64M$80,000.000.0017Gap DownANIXAnixa Biosciences2.8707 of 5 stars$3.05-2.6%$7.00+129.9%+2.9%$97.99M$210,000.00-7.815Analyst ForecastNews CoverageKPTIKaryopharm Therapeutics3.9896 of 5 stars$0.78flat$5.00+545.2%-1.5%$96.87M$146.03M0.00380ELYMEliem TherapeuticsN/A$3.25+6.2%N/A+28.0%$96.69MN/A-6.1320CHRSCoherus BioSciences3.8225 of 5 stars$1.10+34.1%$6.13+456.8%-46.9%$94.65M$304.34M-13.75246High Trading VolumeIMUXImmunic3.0869 of 5 stars$1.07+1.9%$12.25+1,044.9%-3.6%$94.58MN/A0.0070MNOVMediciNova0.668 of 5 stars$1.95+2.6%N/A-5.3%$93.19M$1M0.0010News CoverageGap UpMISTMilestone Pharmaceuticals2.6273 of 5 stars$1.86+6.9%$12.00+545.2%-18.4%$92.79M$1M0.0030ORMPOramed Pharmaceuticals1.4846 of 5 stars$2.26-1.7%N/A+4.6%$92.72M$1.34M4.4310News CoverageADAGAdagene2.9782 of 5 stars$2.09-5.9%$5.00+139.2%+52.6%$92.53M$815,746.000.00260News CoveragePositive NewsGap UpIVVDInvivyd2.5274 of 5 stars$0.77flat$7.52+878.6%-48.8%$91.88M$11.56M-0.39100Analyst Forecast Related Companies and Tools Related Companies ANIX Competitors KPTI Competitors ELYM Competitors CHRS Competitors IMUX Competitors MNOV Competitors MIST Competitors ORMP Competitors ADAG Competitors IVVD Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:GOVX) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GeoVax Labs, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share GeoVax Labs With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
